XML 99 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies - Calculation of Net Loss Per Share (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator                      
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (37,662,038) $ (23,090,693) $ (29,387,226) $ (29,219,262)         $ (119,359,219) $ (96,967,830) $ (88,205,772)
Adjustment for decrease in fair value of warrant liability                 0 0 (806,819)
Numerator for use in diluted net loss per share                 $ (119,359,219) $ (96,967,830) $ (89,012,591)
Denominator                      
Weighted average number of common shares outstanding (denominator for use in basic net loss per share) (shares)                 98,717,999 92,539,997 81,777,493
Effect of dilutive potential common shares (shares)                 0 0 140,529
Denominator for use in diluted loss per share (shares)                 98,717,999 92,539,997 81,918,022
Net loss per share, diluted ($ per share) $ (0.38) $ (0.25) $ (0.30) $ (0.30) $ (0.34) $ (0.27) $ (0.08) $ (0.36) $ (1.21) $ (1.05) $ (1.09)
Net loss per share, basic ($ per share) $ (0.38) $ (0.23) $ (0.30) $ (0.30) $ (0.34) $ (0.27) $ (0.07) $ (0.36) $ (1.21) $ (1.05) $ (1.08)